(Q46589184)

23 December 2017

title

Molecular analysis of secondary kinase mutations in imatinib-resistant gastrointestinal stromal tumors (English)

1 reference

23 December 2017

author name string

Ken-Hong Lim

1

1 reference

23 December 2017

Ming-Jer Huang

2

1 reference

23 December 2017

Li-Tzong Chen

3

1 reference

23 December 2017

Tsang-En Wang

4

1 reference

23 December 2017

Chien-Liang Liu

5

1 reference

23 December 2017

Cheng-Shyong Chang

6

1 reference

23 December 2017

Mei-Chin Liu

7

1 reference

23 December 2017

Reuy-Kuen Hsieh

8

1 reference

23 December 2017

Chin-Yuan Tzen

9

1 reference

23 December 2017

publication date

6 October 2007

1 reference

23 December 2017

published in

Medical Oncology

1 reference

23 December 2017

volume

25

1 reference

23 December 2017

page(s)

207-213

1 reference

23 December 2017

issue

2

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1007/s12032-007-9014-2

exact match

0 references

cites work

Clinical manifestations and prognostic factors in patients with gastrointestinal stromal tumors

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12032-007-9014-2

Late resistance to imatinib therapy in a metastatic gastrointestinal stromal tumour is associated with a second KIT mutation

21 January 2018

1 reference

12 December 2020

Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation

1 reference

12 December 2020

Molecular correlates of imatinib resistance in gastrointestinal stromal tumors.

1 reference

12 December 2020

Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants

1 reference

12 December 2020

KIT/Val654 Ala receptor detected in one imatinib-resistant GIST patient.

1 reference

12 December 2020

Biology of gastrointestinal stromal tumors.

1 reference

12 December 2020

A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors

1 reference

12 December 2020

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

1 reference

12 December 2020

PDGFRA activating mutations in gastrointestinal stromal tumors.

1 reference

12 December 2020

PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib

1 reference

12 December 2020

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

1 reference

12 December 2020

Gastrointestinal Stromal Tumors, Intramural Leiomyomas, and Leiomyosarcomas in the Duodenum: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 167 Cases

1 reference

12 December 2020

Gastrointestinal stromal tumors in Iceland, 1990-2003: the icelandic GIST study, a population-based incidence and pathologic risk stratification study.

1 reference

12 December 2020

Polyclonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors under treatment with imatinib mesylate

1 reference

12 December 2020

Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutations

1 reference

12 December 2020

Incidence of gastrointestinal stromal tumor: a retrospective study based on immunohistochemical and mutational analyses.

1 reference

12 December 2020

Resistance to imatinib, low-grade FDG-avidity on PET, and acquired KIT exon 17 mutation in gastrointestinal stromal tumour

1 reference

12 December 2020

Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era--a population-based study in western Sweden

1 reference

12 December 2020

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

1 reference

12 December 2020

Imatinib binding and cKIT inhibition is abrogated by the cKIT kinase domain I missense mutation Val654Ala

1 reference

12 December 2020

A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient

1 reference

12 December 2020

10.1007/S12032-007-9014-2

Identifiers

DOI

1 reference

23 December 2017

PubMed ID

18488160

1 reference

23 December 2017